Skip to main content

Table 1 Patients’ characteristics

From: Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study

Variables N %
Age
 Median 62.5  
 Quartiles 50.3-69  
Gender
 Female VS Male 26:26 50: 50
Clinical stage
 III B VS IV 3:49 5.8: 94.2
Histological diagnosis
 Adenocarcinoma VS Others 51:1 98.1: 1.9
Anti-EGFR therapy
 Gefitinib 34 65.4
 Erlotinib 7 13.5
 Ectinib 9 17.3
 Ositinib 2 3.8
Other treatments
 Thoracic surgery 2 4.3
 Radiotherapy 2 4.3
 Chemotherapy 39 82.9
 Radiofrequency ablation 3 6.4
 Radioactive seed implantation 1 2.1
Concomitant diseases
 Arterial hypertension 14 43.7
 Diabetes mellitus 9 28.1
 Heart disease 3 9.4
 Chronic obstructive pulmonary disease 3 9.4
 Cerebral infarction 3 9.4
Smoking
 Past/current 17 32.7
 Never 35 67.3
D-dimer content
 Decrease VS Increase 37:15 71.2: 28.8
Platelet count
 Decrease VS Increase 33: 19 63.5: 36.5
\